Clinical Trials Directory

Trials / Completed

CompletedNCT05221567

Intensive Psychotherapy for Chronic Depression

The Effectiveness of Intensive Psychotherapy for Chronic Depression: A Naturalistic Comparison With Treatment-as-Usual

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
280 (actual)
Sponsor
Modum Bad · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study evaluates whether Intensive psychotherapy show superior effect on chronic depression over TAU

Detailed description

Background: Accumulating evidence indicates that intensive psychotherapy (i.e., greater number of treatment sessions per time unit) improves outcomes for patients with mental health problems. However, few studies have investigated whether patients with chronic depression (CD) benefit from treatment with higher intensity. The main purpose of this study is to investigate if intensive psychotherapy could improve treatment for patients with chronic depression (CD). The primary research question is whether two intensive psychodynamic inpatient treatments, affect phobia therapy (APT) and VITA, are superior to low intensity treatment (TAU) at completion of treatment. To indicate if a potential difference between intensive treatment and TAU is due to the intensity of the therapy, the study contrasts two therapies with similar intensity, but different theoretical rationales. Methods: 280 patients with CD are included in a naturalistic study. Patients are assessed at four time points; assessment, start of therapy, end of therapy and 1-year follow-up. Three comparisons are performed with patients matched across groups; Intensive treatment (APT + VITA) vs TAU during treatment, APT vs VITA during treatment and APT vs VITA during follow-up. The outcome measure is the BDI-II.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychotherapyIntensive psychotherapy (i.e., greater number of treatment sessions per time unit)

Timeline

Start date
2012-01-01
Primary completion
2017-12-31
Completion
2017-12-31
First posted
2022-02-03
Last updated
2022-02-03

Source: ClinicalTrials.gov record NCT05221567. Inclusion in this directory is not an endorsement.